Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib)

AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...

Pfizer Covid Pill Europe’s First Approved Oral Treatment Against Covid

Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the...

FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. As we have throughout the COVID-19 pandemic,...

Australia has recognized Russia’s Sputnik V COVID-19 vaccine for international travellers

International travellers who have had two doses of the Russian Sputnik V vaccine will be permitted to enter Australia now that the Therapeutic Goods...

EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty

EMA has started evaluating an application for the use of a booster dose of Comirnaty to be given 6 months after the second dose...

Falsified COVISHIELD vaccine identified in the WHO regions of Africa and South- East Asia

WHO requests increased vigilance within the supply chains of countries and regions likely to be affected by these falsified products.
spot_img

Expert Articles

spot_img